Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
3
Neutral
5
Bullish
6
Bearish
30
Neutral
5
Bullish
11
Bearish
27
Neutral
0
Bullish
5
Upcoming Result Date: Nov 04, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Discovery themes featuring this stockInsecticides India Ltd (INSECTICID) is currently trading at 519.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Insecticides (India) Limited manufactures and distributes crop protection and nutrition products—spanning insecticides, herbicides, fungicides, plant growth regulators and biologicals—operating manufacturing units at Chopanki (Rajasthan), Samba (J&K), Dahej and expanding Sotanala, with integrated technical and formulation capabilities and an R&D center focused on India-specific molecules and formulations. Q1 FY27 showed operational seasonality and input-cost pressure: revenue from operations declined 12% year-on-year to INR612 crore while gross profit declined modestly but gross margin expanded to 31.6%; EBITDA fell about 20% with margin at 11.1% and PAT margin declined to 7.2%, reflecting volume weakness, elevated inventories and strategic placements amid delayed monsoon-driven demand. Premiumization is a clear strategic lever: premium portfolios (Maharatna and Focus Maharatna) contributed approximately 64% of B2C sales this quarter with management targeting about 70% contribution within three to four years; product launches with partners (GRANUVIA, Spinoace) plus strong farmer engagement are positioned to convert into multi-year high-margin revenue streams. Capital intensity is large but nearing normalization: Sotanala is a ~INR200 crore project (INR150 crore technicals, INR50 crore formulations) with ~INR70 crore spent so far and staged commissioning planned; management expects capex to normalize to INR30–40 crore annually after current projects complete, shifting emphasis to utilization, cash generation and ROCE improvement. IIL is also scaling Kaeros Research as a second growth platform, expanding international registrations across Latin America, Europe and ASEAN, and conducting intensive farmer and channel engagement (over 3,600 meetings, 600 field days and thousands of demonstrations) to accelerate adoption of differentiated and co-branded products.
Over the past 52 weeks, Insecticides India Ltd has traded between a low of ₹500.00 and a high of ₹775.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Insecticides India Ltd has a market capitalization of approximately 1,487.19. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Insecticides India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 11.88 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,487.19 Cr, Insecticides India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Insecticides India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Insecticides India Ltd is 11.88. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The stock fell over 9% because the company's net profit declined by nearly 40% year-on-year, and its operating margins narrowed despite an increase in revenue.
Insecticides (India) Limited manufactures and distributes crop protection and nutrition products—spanning insecticides, herbicides, fungicides, plant growth regulators and biologicals—operating manufacturing units at Chopanki (Rajasthan), Samba (J&K), Dahej and expanding Sotanala, with integrated technical and formulation capabilities and an R&D center focused on India-specific molecules and formulations.
Q1 FY27 showed operational seasonality and input-cost pressure: revenue from operations declined 12% year-on-year to INR612 crore while gross profit declined modestly but gross margin expanded to 31.6%; EBITDA fell about 20% with margin at 11.1% and PAT margin declined to 7.2%, reflecting volume weakness, elevated inventories and strategic placements amid delayed monsoon-driven demand.
Premiumization is a clear strategic lever: premium portfolios (Maharatna and Focus Maharatna) contributed approximately 64% of B2C sales this quarter with management targeting about 70% contribution within three to four years; product launches with partners (GRANUVIA, Spinoace) plus strong farmer engagement are positioned to convert into multi-year high-margin revenue streams.
Capital intensity is large but nearing normalization: Sotanala is a ~INR200 crore project (INR150 crore technicals, INR50 crore formulations) with ~INR70 crore spent so far and staged commissioning planned; management expects capex to normalize to INR30–40 crore annually after current projects complete, shifting emphasis to utilization, cash generation and ROCE improvement.
IIL is also scaling Kaeros Research as a second growth platform, expanding international registrations across Latin America, Europe and ASEAN, and conducting intensive farmer and channel engagement (over 3,600 meetings, 600 field days and thousands of demonstrations) to accelerate adoption of differentiated and co-branded products.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
1,513 Cr
Low Risk
12.1
18.4
0.6
1.2
775.70
500.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
932.00 | 1,578 Cr | 11.01 | 1.24 | 0.05 | 11.43 | 15.51 | 10.00 | ||
519.80 | 1,487 Cr | 11.88 | 1.22 | 0.39 | 11.42 | 14.78 | 6.26 | ||
52.43 | 1,395 Cr | 21.72 | 0.90 | 0.00 | 1.86 | 6.75 | 2.13 | ||
112.90 | 1,346 Cr | 12.50 | 1.33 | 0.64 | 11.86 | 15.46 | 8.06 | ||
543.35 | 1,295 Cr | -16.28 | 3.87 | 0.00 | -23.77 | -7.49 | -10.01 | ||
949.60 | 1,180 Cr | 18.05 | 2.79 | 0.31 | 15.10 | 17.43 | 7.95 | ||
254.55 | 868 Cr | 14.43 | 1.93 | 0.00 | 12.17 | 15.44 | 7.15 | ||
| Median: 7 Co. | — | 519.80 | 1,346 Cr | 12.50 | 1.33 | 0.05 | 11.43 | 15.44 | 7.15 |
